Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Chiurlo

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The New Microbiologica|July 9, 2021
Invasive fungal infections in patients with COVID-19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomesMatteo Chiurlo, Andrea Mastrangelo, Marco Ripa, et al.
Idcases|July 28, 2023
Probable West Nile Virus hepatitis: Case reportGiovanni Mori, Martina Strano, Matteo Chiurlo, et al.
Infectious Diseases and Therapy|July 24, 2021
Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case SeriesEmanuela Messina, Anna Danise, Giulio Ferrari, et al.
Drug Design, Development and Therapy|April 15, 2024
Outcome of Darunavir-Cobicistat-Based Regimens in HIV-Infected People Who Have Experienced Virological FailureFrancesca Alberton, Laura Galli, Riccardo Lolatto, et al.
AIDS (London, England)|May 16, 2021
Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1-infected patientsClaudia Pastori, Laura Galli, Gabriel Siracusano, et al.
Drug Design, Development and Therapy|December 13, 2023
Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment: Efficacy and Tolerability in Clinical PracticeDiana Canetti, Laura Galli, Riccardo Lolatto, et al.
The New Microbiologica|November 2, 2020
SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 PandemicDiana Canetti, Raffaele Dell'Acqua, Niccolò Riccardi, et al.
Drug Design, Development and Therapy|July 5, 2022
Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical PracticeMartina Ranzenigo, Nicola Gianotti, Laura Galli, et al.
Bone Marrow Transplantation|April 24, 2025
Risk stratification and impact of donor type on breakthrough invasive fungal infections in haematopoietic cell transplant with post-transplant cyclophosphamide and mould-active prophylaxisMatteo Chiurlo, Laura Galli, Francesca Farina, et al.
Microorganisms|January 23, 2024
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological MalignanciesGiovanni Mori, Sara Diotallevi, Francesca Farina, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The New Microbiologica|July 9, 2021
Invasive fungal infections in patients with COVID-19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomesMatteo Chiurlo, Andrea Mastrangelo, Marco Ripa, et al.
Idcases|July 28, 2023
Probable West Nile Virus hepatitis: Case reportGiovanni Mori, Martina Strano, Matteo Chiurlo, et al.
Infectious Diseases and Therapy|July 24, 2021
Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case SeriesEmanuela Messina, Anna Danise, Giulio Ferrari, et al.
Drug Design, Development and Therapy|April 15, 2024
Outcome of Darunavir-Cobicistat-Based Regimens in HIV-Infected People Who Have Experienced Virological FailureFrancesca Alberton, Laura Galli, Riccardo Lolatto, et al.
AIDS (London, England)|May 16, 2021
Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1-infected patientsClaudia Pastori, Laura Galli, Gabriel Siracusano, et al.
Drug Design, Development and Therapy|December 13, 2023
Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment: Efficacy and Tolerability in Clinical PracticeDiana Canetti, Laura Galli, Riccardo Lolatto, et al.
The New Microbiologica|November 2, 2020
SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 PandemicDiana Canetti, Raffaele Dell'Acqua, Niccolò Riccardi, et al.
Drug Design, Development and Therapy|July 5, 2022
Switching from a Non-Protease inhibitor-Based Regimen To the Fixed Dose Combination of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Clinical PracticeMartina Ranzenigo, Nicola Gianotti, Laura Galli, et al.
Bone Marrow Transplantation|April 24, 2025
Risk stratification and impact of donor type on breakthrough invasive fungal infections in haematopoietic cell transplant with post-transplant cyclophosphamide and mould-active prophylaxisMatteo Chiurlo, Laura Galli, Francesca Farina, et al.
Microorganisms|January 23, 2024
High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological MalignanciesGiovanni Mori, Sara Diotallevi, Francesca Farina, et al.
Pageof 2